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Abstract
Pectus excavatum, the most frequent con-
genital chest wall deformity, may be rarely
observed as a sole deformity or as a sign of an
underlying connective tissue disorder. To date,
only few studies have described correlations
between this deformity and heritable connec-
tive tissue disorders such as Marfan, Ehlers-
Danlos, Poland, MASS (Mitral valve prolapse,
not progressive Aortic enlargement, Skeletal
and Skin alterations) phenotype among oth-
ers. When concurring with connective tissue
disorder, cardiopulmonary and vascular
involvement may be associated to the thoracic
defect. Ruling out the concomitance of pectus
excavatum and connective tissue disorders,
therefore, may have a direct implication both
on surgical outcome and long term prognosis.
In this review we focused on biological bases
of connective tissue disorders which may be
relevant to the pathogenesis of pectus excava-
tum, portraying surgical and clinical implica-
tion of their concurrence.
Introduction
Pectus Excavatum (PE), the most frequent
congenital chest wall deformity, is character-
ized by anomalous growth of several ribs and
sternum, which makes the chest hollow
(Figure 1). PE occurs in 1 in 300-1000 live
births with a male/female ratio of approxi-
mately 4:1 with a tendency to become more
evident during adolescence.1-4 The causes of
PE are still unclear; although a familial predis-
position has been observed and nearly half of
the patients have relatives with various skele-
tal alterations, a direct genetic link has not yet
been recognized.5,6 Patients with a non-syn-
dromic familial isolated deformity have been
described as a rare occurrence.7 Progression
may be particularly evident during adoles-
cence, an information unfamiliar to a lot of
pediatricians who erroneously inform younger
patients that this condition will resolve sponta-
neously with growth. At time of puberty, when
patients grow rapidly, such deformity often
abruptly accelerates, and a mild defect may
quickly turn into severe. Usually this situation
alarms parents and induces them to seek sur-
gical consultation despite their pediatrician’s
reassurance.8 Surgical repair of PE in most of
the cases has a cosmetic indication. Since
most patients with the deformity do not have
other associated symptoms, treatment may not
be strictly needed and will be dependent upon
the development of symptoms or lack of self-
acceptance. Although still unclear, physiother-
apy in young patients may play a beneficial
role slowing the development of the chest wall
deformity and may possibly correct milder
forms. The primary goal of surgical repair is to
correct the chest deformity which improves
first of all self-acceptance and may ameliorate
patient’s breathing, posture and cardiac func-
tion. A variety of surgical procedures were
developed in order to correct the defect by for-
ward repositioning of the sternum. In 1949,
Ravitch described a repair technique requiring
subperichondrial resection of all deformed
costal cartilages, xiphoid excision and trans-
verse sternal osteotomy displacing the ster-
num anteriorly9,10 (Figure 2A). Some decades
later, in 1998, a minimally invasive technique
was developed by Nuss. This procedure
involves placement under thoracoscopic view
of a curved substernal bar which is placed and
flipped into the chest acquiring concavity fac-
ing posteriorly in order to push sternum out-
ward (Figure 2B). The bar is then removed
after about three years, a period after which
the chest is supposed to have acquired a stable
structure.9-11 Nuss technique promptly gained
a widespread approval, especially because in a
different way from Ravitch procedure, it does
not produce any visible scar in the anterior
aspect of the chest. To date, several compara-
tive studies in order to outline the real benefits
of either techniques were published with
inconsistent results;10,12-19 a systematic review
and meta-analysis failed to provide over-
whelming support to either approach, conclud-
ing that the use of validated pain scales or sat-
isfaction surveys and the quantification of
total narcotics would be helpful.20
Patient age at the time of surgery is impor-
tant for both speed of recovery and long-term
results.11 Unlike the more invasive procedures
such as Ravitch, there is no interference with
growth plates when using Nuss procedure.21,22
This evidence supports the fact that the latter
procedure is feasible at any age.
Concerns have been raised in patients
younger than 6 years, since there are many
years of subsequent growth during which the
pectus excavatum may recur.8 Some authors
agree that the optimal age is 7 to 14 years,
because, before puberty, the patients’ chests
are still soft and malleable; they show quick
recovery, a rapid return to normal activities,
and have excellent results.11 After puberty, the
flexibility of the chest wall is decreased,
requiring the insertion of two bars, making the
procedure more difficult. It also takes the
patients longer to recover.8 Long-term results,
however, are superior in grown-up patients,
particularly for those who have completed their
growth at the time of bar removal. Since
regression or improvement of PE is not related
to cartilage and ligament fixation, the ideal
phase for optimal PE correction should be
around adolescence, when the costal cartilages
are still plastic and flexible.23 In addition to
this, since it is not negligible to share the indi-
cation for surgery among both parents and
patient, at our Institution the procedure is car-
ried out mainly in adolescents which are able
to demonstrate a complete awareness of such
surgical procedure.
In regards to clinical implications of surgical
correction, the release of cardiac compression
caused by the sunken chest is one of the most
significant clinical consequence of surgical
repair of PE. Previous reports and meta-analy-
ses, supported by the hypothesis that the
release of cardiac compression in PE patients
improves the hemodynamic function, have
been carried out demonstrating that cardiac
function improves after surgical correction of
PE.24-26 On the other hand, lung function
improvement after surgical repair of PE is not
yet generally accepted. In particular, it is still
uncertain whether the pathophysiologic
deficits in PE are primarily ventilatory or car-
diovascular. Surgical management may
increase a patient’s exercise tolerance and
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reduce symptoms because a depressed ster-
num compresses the right ventricular outflow
tract and this anatomical constraint may pro-
duce in turn diminished lung capacity, arising
with frequent respiratory tract infection, dysp-
nea, and pulmonary insufficiency.27,28 The
post-operative cardiovascular and respiratory
improvements are particularly applicable to
patients with severe deformities, because sur-
gery may increase significantly chest volume,
making space available for lung expansion.29 A
recent meta-analysis including a total of 2476
PE patients operated with either techniques,
showed that although both procedures for the
correction of PE displayed the same improve-
ments in pulmonary function within 1 year
after the procedure, Nuss technique showed
an additional enhancement in pulmonary
function after bar removal.23 In any case, there
is still a need for further large-scale prospec-
tive trials and meta-analyses to better assess
the extent of the beneficial effects of PE cor-
rection on pulmonary function.
PE may be frequently associated with herita-
ble disorders of the connective tissue, such as
MFS, Ehlers-Danlos, Poland, Mitral valve pro-
lapse or MASS syndromes.30-32 Roughly half of
the patients with MFS have a concurring
PE.30,33-35 However, apart from limited reports
on MFS,30,33-35 Ehlers-Danlos,33 and MASS phe-
notype,2 to date only few studies have
described correlations between PE and con-
nective tissue disorders.
Aetiopathogenesis of PectusExcavatum
Many hypotheses have been proposed to
explain the pathogenesis of PE, such as
intrauterine compression, rickets, pulmonary
restriction, diaphragm alterations resulting in
posterior traction on the sternum, and primary
failure of osteogenesis or chondrogenesis.5
The prevailing hypothesis has long been over-
growth of costal cartilage, further intensified
during growth spurts, which pushes the ster-
nal body inward.36,37 This theory was firstly
introduced by Sweet in 1944 and many sur-
geons supported this theory subsequently,37  as
none reported about the length of costal carti-
lage until Nakaoka.38 Nakaoka et al. measured
costal cartilage length in PE patients and
healthy controls from reconstructed images of
three-dimensional computed tomography,
where costal cartilage in PE patients resulted
to be not any longer than in healthy controls.38
Several studies have then focused on histology
and biochemistry of costal cartilage, albeit the
results to date remain still inconclusive.
Collagen type II is a major structural compo-
nent of rib cartilage, therefore its metabolism
and composition may play an important role in
the aetiology and pathogenesis of PE.36
Biochemical and immunohistochemical analy-
ses have shown abnormalities in the structure
such as altered distribution and arrangement
of type-2 collagen in costal cartilage, abnormal
high levels of zinc and low levels of magne-
sium and calcium plus disturbance of collagen
synthesis.5,39 Electron microscopy studies have
revealed degenerated chondrocytes with fat
droplets and other osmiophilic inclusions not
better characterized, as well as atypical fibrils
including long-spacing collagen.39 Additional
data indicate that PE patients also exhibit dis-
orders in endochondral ossification and alter-
ations in the metabolism of acid mucopolysac-
charides.5,40 Vacuolisation, polymorphism and
nuclear pyknosis, along with higher cell num-
ber density, more variable cellular distribution,
and more frequent myxoid matrix degenera-
tion with focal necrosis occur which may
reflect increased growth and decreased struc-
tural integrity in the presence of additional
mechanical stress in PE patients and, to a cer-
tain extent, premature cartilage ageing.36 All
the aforementioned alterations certainly indi-
cate an abnormality in connective tissue biolo-
gy which affects, among others, the ribs and
sternum and which may contribute to the
development of PE.41 Feng et al. have analysed
the biomechanical properties of costal carti-
lage and showed that the biomechanical stabil-
ity of costal cartilage in children with PE is
impaired in response to tension, compression,
and bending. Those authors have proposed
that the abnormal costal cartilage in children
with PE is unable to resist the stress of the res-
piratory gradient, leading to the formation of
funnel chest. Furthermore, the movement of
diaphragm, a main fetal breathing activity,
might cause retraction of the weak costal car-
tilages and make them angled posteriorly so
that PE would be present at birth. Unusual
inspiratory efforts, as in case of crying spells,
respiratory obstruction or hiccupping, might
aggravate the effect of inspiratory retraction
on the anterior sixth rib cartilage because of
the strong spastic contraction of the
Review
Figure 1. Chest picture of an adolescent
affected by a moderate/severe form of pec-
tus excavatum. Written consent was
obtained from the patient and the patient's
parents for publication of this image.
Figure 2. Two surgical techniques are described. The first one, popularized by Ravitch
(A), entails an anterior approach through which costal cartilages are removed and the
sternum detached. The latter, proposed by Nuss (B) consists in the insertion of one or
two concave steel bars into the chest, underneath the sternum. The bar is then flipped to
a convex position so as to push outward on the sternum, correcting the deformity.
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diaphragm, and might induce or aggravate the
deformity.41 This hypothesis is supported by
the fact that the PE is more frequent in chil-
dren with respiratory obstruction.41,42 Lastly, a
recent study on 34 families provided evidence
that PE can be an inherited disorder. Although
some families demonstrated mendelian inher-
itance, most cases appeared to have multifac-
torial genetic background. It is reported that in
families of individuals affected by PE there are
relatives which have connective tissue disease
traits, suggesting that PE may be due, in part,
to some deficit in connective tissue disorders-
related genes such as FBN, collagen, and TGF.5
Heritable disorders of connec-tive tissue
Heritable disorders of connective tissue
(HDCTs) comprise a group of genetic disor-
ders affecting proteins of connective tissue
matrix, such as collagens, proteoglycans,
elastins, fibrillins and laminins.43,44 HDCTs
are described in Berlin International Nosology
(1986) which defines several disorders such
as MFS, MASS phenotype among others
(Stickler syndrome, Ehlers-Danlos syndrome,
Familial Articular Hypermobility syndrome,
Skeletal Dysplasias with predominant joint
laxity, Cutis Laxa, Pseudoxanthoma
Elasticum, Epidermo lysis Bullosa, HDCTs sec-
ondary to metabolic defects, copper transport
disorders, Osteogenesis Imperfecta, miscella-
neous HDCTs).45 HDCTs generally result from
single gene mutations and the patterns of
inheritance may be autosomal dominant,
autosomal recessive or X-linked.46 Abnormal
folding and aggregation of the matrix macro-
molecules are caused by incorporation of one
or more mutant polypeptides. Consequently,
mutations which cause synthesis of struc-
turally altered polypeptide chains usually pro-
duce more severe phenotypes than heterozy-
gous null alleles.45 Fibrillin (FBN) proteins are
the major components of extracellular
microfibrils found in many connective tissues,
elastic and non-elastic tissues.47 There are
three human fibrillins, fibrillin-1, -2 and -3,
which are encoded by different genes.48 FBN1
and FBN2 are well studied and mutations in
these proteins cause a number of fib-
rillinopathies including MFS and congenital
arachnodactily, respectively. FBN3 has been
discovered more recently and is less well char-
acterized. FBN1, the main component of the
microfibrils which together with elastin form
elastic fibres, is expressed throughout life,
whereas FBN2 and FBN3 are thought to be pri-
marily present during development.47 FBN1
serves two key physiological functions: it par-
ticipates to the assembly of specialized, struc-
turally relevant fibres within the extracellular
matrix and provides context dependent modu-
lation of TGF and bone morphogenetic protein
(BMP) signalling, which in turn regulate
matrix formation and remodeling.48 FBN1 is a
230-Kb gene containing 65 exons, situated on
chromosome 15q21. More than 1750 muta-
tions in FBN1 gene 1 are registered in the
Universal Marfan Database (UMD)-FBN1 for
MFS and its associated disorders. These
include point mutations, large and small dele-
tions, insertions, missense and splice muta-
tions. Premature termination codon (PTC)
and in-frame mutations are two major muta-
tion categories in FBN1.48,49 FBN1 mutations
have been associated with different clinical
phenotypes: MFS, MASS phenotype, ectopia
lentis syndrome, mitral valve prolapse syn-
drome, Shprintzen-Goldberg syndrome and
Loeys-Dietz syndrome.50,51 MFS is a systemic
autosomal dominant connective tissue disor-
der caused by several mutations in the gene
encoding the glycoprotein FBN1. MFS has an
incidence of 2-3 cases in 10,000,30,33 whilst PE
is present in two thirds of patients with
MFS.30,33-35 MFS clinical manifestations vary
in range and severity and may involve several
organs:51,52 cardiovascular diseases (aortic
dilatation and dissection) are the major cause
of morbidity and mortality.53,54 First in 1989,
Glesby proposed the acronym MASS to define a
group with concurrence of clinical features
such as mitral valve prolapse,55 not progres-
sive aortic enlargement, skeletal and skin
alterations. MASS belongs to connective tis-
sue disorders characterized by slight, general-
ized laxity. In patients with MASS phenotype,
aortic root diameter may be at the upper lim-
its of normal for body size, but there is no doc-
umented progression to aneurysm or predis-
position to dissection and the finding is of lim-
ited clinical value;32,51,53,55,56 these patients do
not suffer from ectopia lentis (Table 1).32,51,56
MASS is described as an autosomal dominant
disease and is caused by mutations in the
FBN1 gene,32,57,58 which encodes the protein
fibrillin 1 (FBN1) and appears to be common-
ly concurrent with PE.2 The prominent
hypotheses on the pathogenesis of MFS, the
most studied fibrillinopathy, focused both on
the structural weakness of the tissues
imposed by microfibrillar deficiency and
upregulation of Transforming Growth Factor-β
(TGFβ) signalling pathway.48,49 FBNs consti-
tute the major backbone of multifunctional
microfibrils in elastic and non-elastic extra-
cellular matrices. FBN1 mutations have been
shown to increase the susceptibility of FBN1
to proteolysis in vitro leading to fragmentation
of microfibrils.48 Fragmentation and disorgan-
ization of the elastic fibres in the aortic media
layer is a histological marker of MFS, known
as medial degeneration where the properties
of microfibrils are often compromised because
of their aberrant folding and assembly.48
Recent findings suggest that proteolysis due
to increased metalloproteinase (MMP) activi-
ty, and consequent fragmentation of microfib-
rils in tissues of MFS patients may also con-
tribute to the pathogenesis of this disorder.
Therefore, FBN1 fragments may regulate
MMP-1 expression, and MMPs dysregulation
caused by fibrillin fragmentation may con-
tribute to the development of MFS. Further
findings also support an interaction between
altered extracellular matrix and aberrant TGF
signalling in MFS pathogenesis.48 An excessive
TGF  signalling characterizes the progression
of aortic aneurysm in mouse models of MFS,
possibly because FBN1 mutations promote
abnormal Smad signalling by impairing the
sequestration of latent TGF  complexes into the
extracellular matrix.48,59 Although molecular
testing for FBN1 mutations is usually available
at present, the diagnosis of MFS cannot rely
only on the demonstration of a gene muta-
tion,53,60 because of the large clinical variabili-
ty and genetic heterogeneity. This implies that
MFS still remains a clinical diagnosis and
depends on a combination of major and minor
signs as defined by Ghent criteria proposed in
1996 (Table 2).32,53,61,62 Among these criteria, a
severe PE which necessitates a surgical repair,
for example, is a major one for MFS diagno-
sis.30,60 More recently, in 2010, Ghent criteria
were revised and major changes were intro-
duced.56 More importance was given to two car-
dinal features: aortic dilatation and ectopia
lentis, which are now considered sufficient for
diagnosis when concomitant. A more promi-
nent role was assigned to molecular genetic
testing of FBN1 and other relevant genes (e.g.
TGFBR1, TGFBR2), whilst other less specific
features (like recurrent or incisional hernia,
apical blebs) were removed or considered less
Review
Table 1. Diagnostic criteria for the MASS (Mitral valve prolapse, not progressive Aortic
enlargement, Skeletal and Skin alterations) phenotype.
1 Mitral valve prolapse
2 Borderline and non-progressive aortic enlargement
3 Not specific skeletal alterations (pectus excavatum, long limbs)
4 Not specific skin alterations (striae atrophicae)
5 Myopia (non ectopia lentis)
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influential in the diagnostic evaluation. The
revised criteria were simplified in order to
facilitate a prompt diagnosis, providing specific
recommendations for patients counseling and
follow-up.56,63 Authors which applied the
revised Ghent criteria to a large cohort of MFS
patients, concluded that the definition of aortic
root dilatation based on Z-score alone may
underestimate aortic involvement, represent-
ing a pitfall in the revised criteria. Therefore, a
re-evaluation of the aortic involvement criteria
in adult patients with suspected MFS diagnosis
may be warranted.63
Discussion
As previously reported, biochemical and
histopathological studies in PE patients have
shown abnormalities in the costal carti-
lage,5,36,39 and this presumably implies that
nearly the totality of patients affected by PE
displays various degrees of connective tissue
laxity. Although PE is seen in individuals with
primary connective tissue defects, it is likely
that the outcome of these patients, when sur-
gically treated, differs from those who have
only chest deformity without signs of heritable
connective tissue disorder.
A few studies have addressed the surgical
outcome of patients upon operation for the cor-
rection of PE with or without associated con-
nective tissue disorder. In a comparison
between seven children affected by PE and
MFS and 38 ones affected by sole deformity,
the authors claimed that they had to use a sub-
sternal strut to ensure a satisfactory correction
of the defect especially in MFS patients.35
These results have been confirmed also by
other authors.30,34 In a report of 28 patients
with MFS and 30 patients with a supposed sole
deformity it was concluded that PE may be a
Review
Table 2 . Diagnostic criteria for the Marfan Syndrome (Ghent Nosology).
Skeletal system Major criteria Pectus carinatum
(at least 4 of the following Pectus excavatum, needing surgery
constitutes a major criterion) Reduced upper to lower segment ratio or arm span to height ratio >1.05
Positive wrist and thumb signs
Scoliosis >20° or spondylolisthesis
Reduced extension of the elbows (>170°)
Medial displacement of the medial malleolus causing pes planus
Protrusio acetabuli of any degree, ascertained on x-ray
Minor criteria Pectus excavatum of moderate severity
Joint hypermobility
Facial appearance (dolicocephaly, malar hypoplasia, enophthalmos, retrognathia, 
down-slanting palpebral fissures)
Highly arched palate with dental crowding
Ocular system Major criteria Ectopia lentis
Minor criteria Abnormally flat cornea (as measured by keratometry)
Increased axial length of globe (as measured by ultrasound)
Cardiovascular Major criteria Dilatation of the ascending aorta with or without aortic 
system regurgitation and involving at least the sinuses of Valsalva
Dissection of the ascending aorta
Minor criteria Mitral valve prolapse with or without mitral valve regurgitation
Dilatation of main pulmonary artery, in the absence of valvular 
or peripheral pulmonary stenosis or any other obvious cause, under the age of 40 years
Calcification of the mitral annulus below the age of 40 years
Dilatation or dissection of the descending thoracic or abdominal aorta below the age of 50 years
Pulmonary system Major criterion None
Minor criterion Spontaneous pneumothorax
Apical blebs (ascertained by chest radiography)
Skin and integument Major criteria Lumbosacral dural ectasia ascertained by CT or MRI
Minor criteria Striae atrophicae (stretch marks) not associated with marked weight change, pregnancy 
or repetitive stress
Recurrent or incisional herniae
Family/genetic history Major criteria Having a parent, child, or sibling who meets the diagnostic criteria listed below independently
Presence of a mutation in FBN1 known to cause the Marfan syndrome
Presence of a haplotype around FBN1, inherited by descent, known to be associated with 
unequivocally diagnosed Marfan syndrome in the family
Minor criteria None
Requirement Index case Major criteria in at least two different organ systems and involvement of a third 
for diagnosis of organ system
Marfan syndrome Family member Presence of a major criterion in the family history and one major criterion in an organ system and 
involvement of a second organ system
To assess involvement of the skeletal system, at least two major criteria, or one major criterion plus two minor criteria must be present. To assess involvement of the ocular system, the major criterion or at least
two minor criteria must be present. To assess involvement of the cardiovascular system, one major or minor criterion must be present. To assess involvement of the pulmonary system, one of the minor criteria
must be present. To assess involvement of the skin and integument, the major criterion must be present.
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part of a heritable disorder of connective tissue
such as MFS and that in patients with MFS or
other connective tissue diseases surgical
repair should be deferred, whether possible,
until skeletal maturity is nearly established;
moreover, for the cases subjected to surgical
correction the use of an internal stabilization
is strongly recommended.64 A study on a large
series of patients was then published in 2002,
regarding 303 patients affected by PE who
underwent minimally invasive surgical tech-
nique according to Nuss.11 The series con-
tained 16 individuals with MFS and 49 with a
diagnosis of nonspecific connective tissue dis-
ease.65 Among the reported complications, late
failure of the procedure occurred in four
patients, three of which had MFS.
Furthermore, four other patients as a conse-
quence of the surgical procedure developed
overcorrection, three had concurrent MFS and
one had Ehlers-Danlos syndrome.
Nonetheless, in the majority of MFS patients,
the long-term result was reputed excellent.65 In
another similar study, the authors found that
the patients with sole PE did not differ from
those affected by connective tissue diseases
(MFS, Ehlers-Danlos syndrome and nonspecif-
ic connective tissue disease) neither in opera-
tion time nor in estimated mean blood loss nor
in the number of bars needed to achieve cor-
rection. Moreover there was no statistical dif-
ference between the rates of postoperative
complications in the two groups.33 Lastly, in
2010, Redlinger et al.30 studied 3 groups of
patients who underwent surgical repair of PE
and compared the operative and postoperative
results among patients with MFS, those with
marfanoid features, and all other patients and
concluded that there was no difference in
terms of surgical outcome.30 To date there is
no report focusing on the surgical outcome of
patients with MASS phenotype undergoing PE
surgical correction.
In regards to aortic aneurysm and dissec-
tion, which are considered notorious causes of
morbidity and mortality in MFS patients,50,58
there are scarce findings on the evolution of
aortic diameter over time in patients with fea-
tures of connective tissue disorder without full
blown MFS. Mortensen et al. performed an
observational study to assess the evolution of
aortic disease in 78 patients in which MFS was
ruled out, measuring the augmentation index
at a heart rate of 75 beats per minute and cen-
tral pulse pressure (CPP) by applanation
tonometry (APT). During twenty months after
APT, they observed progression of aortic diam-
eters in 15 patients, and aortic surgery or aor-
tic dissection in 3 individuals.57 Rybczynski et
al.60 evaluated prospectively 279 patients with
suspected MFS. They confirmed MFS in 138
individuals and another hereditary disorder of
connective tissue in 69 individuals, in 30 of
which the cardiovascular system was involved.
They concluded that many different, inherited
collagen disorders have a poorly defined car-
diovascular risk, therefore future studies are
required to establish long-term cardiovascular
prognosis. Therefore it is likely that most
patients with an inherited connective tissue
disorder do not progress towards aortic
aneurysm or dissection, but it still remains
unclear how to identify those at increased risk,
especially for patients who do not have the
stigmata of MFS. To sort out this issue, larger
prospective cohorts of patients with detailed
clinical and echocardiographic follow-up over
years are warranted.
It seems clear that several patients affected
by PE display a typical association with con-
nective tissue disorders, which may span from
mild form like simple laxity without morbidity
associated, to more severe forms such as MFS
and Ehlers-Danlos syndrome. Yet at present,
for most of them there is no information on the
risk of complications or about the long-term
prognosis, therefore strategies for clinical
management remain still indefinite, especially
for those patients which undergo a surgical
operation to correct the deformity. Anyway,
when a PE is concurrent with a connective tis-
sue disorder of whatsoever gravity, we reckon
that it is advisable a thorough clinical and
echocardiographic follow-up over time, first of
all because of the possible worsening of mitral
valve prolapse which is a feature present in
many of these patients and secondly to possi-
bly avert the onset of notorious cardiovascular
complications such as aortic dissection, a situ-
ation commonly seen in the most severe con-
nectivopathies.
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